Adult GHD: An interactive debate about diagnosis, dosage, and treatment

During this interactive debate organized in partnership with the World Alliance of Pituitary Organizations (WAPO), the experts talk about the common symptoms of Adult GHD, the lack of consensus on the preferred diagnostic model, the common controversies around starting dosages, novel pharmacological therapies, the benefits and risks of continuing therapy, and important psychological and social well-being factors faced by adult GHD patients.